KTOV vs. OBSV, ADXN, BNOX, CYCN, NCNA, EFTR, CMMB, TENX, ASLN, and HEPA
Should you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include ObsEva (OBSV), Addex Therapeutics (ADXN), Bionomics (BNOX), Cyclerion Therapeutics (CYCN), NuCana (NCNA), eFFECTOR Therapeutics (EFTR), Chemomab Therapeutics (CMMB), Tenax Therapeutics (TENX), ASLAN Pharmaceuticals (ASLN), and Hepion Pharmaceuticals (HEPA). These companies are all part of the "medical" sector.
ObsEva (NASDAQ:OBSV) and Purple Biotech (NASDAQ:KTOV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.
17.5% of ObsEva shares are owned by institutional investors. Comparatively, 30.7% of Purple Biotech shares are owned by institutional investors. 14.4% of ObsEva shares are owned by insiders. Comparatively, 3.0% of Purple Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
ObsEva received 108 more outperform votes than Purple Biotech when rated by MarketBeat users. However, 72.76% of users gave Purple Biotech an outperform vote while only 53.61% of users gave ObsEva an outperform vote.
Purple Biotech has lower revenue, but higher earnings than ObsEva. Purple Biotech is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks.
ObsEva has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500.
ObsEva's return on equity of 0.00% beat Purple Biotech's return on equity.
In the previous week, ObsEva had 1 more articles in the media than Purple Biotech. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for Purple Biotech. Purple Biotech's average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score.
Summary
Purple Biotech beats ObsEva on 7 of the 13 factors compared between the two stocks.
Get Purple Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for KTOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KTOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Purple Biotech Competitors List
Related Companies and Tools
